Publication:
Hereditary angioedema: Report of three cases and approach to diagnosis and management [Herediter anjiyoödem: Üç olgu sunumu ve tani ve tedavide yaklaşim]

dc.contributor.authorsKuş S., Yücelten D.
dc.date.accessioned2022-03-28T14:56:26Z
dc.date.accessioned2026-01-10T18:33:15Z
dc.date.available2022-03-28T14:56:26Z
dc.date.issued2009
dc.description.abstractHereditary angioedema (HAE) is a distinctive form of recurrent angioedema with life threatening consequences. Type I is defined with quantitative C1 esterase inhibitor (C1 INH) deficiency, type II with functional C1 INH deficency and type III with normal quantity and function of C1 INH respectively. Here in, We present three cases with HAE and discuss diagnostic and therapeutic issues.
dc.identifier.issn13077635
dc.identifier.urihttps://hdl.handle.net/11424/256355
dc.language.isotur
dc.relation.ispartofTurk Dermatoloji Dergisi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntifibrinolytic agent
dc.subjectC1 esterase inhibitor (C1 INH)
dc.subjectComplement
dc.subjectDanasole
dc.subjectHereditary angioedema
dc.subjectReticular erythema
dc.titleHereditary angioedema: Report of three cases and approach to diagnosis and management [Herediter anjiyoödem: Üç olgu sunumu ve tani ve tedavide yaklaşim]
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage46
oaire.citation.issue2
oaire.citation.startPage43
oaire.citation.titleTurk Dermatoloji Dergisi
oaire.citation.volume3

Files